TimesSquare Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-665,900
| Closed | -$4.34M | – | 204 |
|
|
2022
Q1 | $4.34M | Buy |
665,900
+6,800
| +1% | +$44.3K | 0.05% | 189 |
|
|
2021
Q4 | $7.68M | Buy |
659,100
+8,500
| +1% | +$99K | 0.07% | 189 |
|
|
2021
Q3 | $12.1M | Sell |
650,600
-32,800
| -5% | -$611K | 0.11% | 195 |
|
|
2021
Q2 | $14.5M | Buy |
683,400
+286,200
| +72% | +$6.07M | 0.12% | 189 |
|
|
2021
Q1 | $8.06M | Sell |
397,200
-27,200
| -6% | -$552K | 0.07% | 196 |
|
|
2020
Q4 | $11.3M | Buy |
424,400
+6,700
| +2% | +$178K | 0.09% | 200 |
|
|
2020
Q3 | $9.36M | Buy |
+417,700
| New | +$9.36M | 0.09% | 203 |
|